Biochemistry and Molecular Biology
- 481
- Oxford BioTherapeutics
- OBT is developing innovative antibody-based cancer drugs, with integrated diagnostics, against novel targets that it has discovered in its unique OGAP proteomic database.
- 482
- Phylogica
- Drug discovery company that is focused on developing protein-based therapies to diseases where there is an unmet medical need, including reducing side effects. Corporate governance, prospectus, announcements, career opportunities and contacts in Subiaco, Western Australia.
- 483
- Protein Analysis
- Offers identification and validation of proteins, drug targets and bio-markers using isotopic labelling and mass spectrometric analysis, including MALDI-MS, PMF, nanoLC-MS/MS.
- 484
- ProteoSys
- Company concentrating on multidimensional proteome analysis for target identification and validation. Includes technology platform, diagnostic marker for Alzheimer, prostate and epithelial cancers, and careers at Mainz, Germany.
- 485
- Proteome Factory
- Offers contract research and products for proteomics, biomarker and target discovery and validation, high sensitive protein identification, characterization and sequencing using its comprehensive PFA proteomics platform.
- 486
- SomaLogic, Inc.
- Introduction to technology and services based on photoaptamer array developing protein signature applications and instrument platforms, for the life sciences research and industry. Includes glossary, publication list and news from Boulder, Colorado.
- 487
- FFEWeber GmbH.
- Develop and promote free flow electrophoresis (FFE) and its application in research of biopolymers and bioparticles. Includes overview, FAQ, related links, specifications and contacts in Planegg, Germany.
- 488
- ProteoChem
- Manufactures analytical standards for NMR and mass spectrometry, protein crosslinkers, and novel proteomics reagents for protein detection and modification that are used in mass spectrometry, drug development, diagnostics and protein biology.
- 489
- Quansys Biosciences
- Offers protein microarrays in a multiplex ELISA format, custom array development and validation and a sample testing service.
- 490
- Target Discovery, Inc.
- Offers dynamic coatings and method development kit to optimize separation, within the pH and buffer ranges by CE and microfluidics electrophoretic chips. Includes technologies under development in metabolomics, expressional and interactional proteomics, and facilities at Palo Alto, California.
- 491
- Australian Proteome Analysis Facility
- Offers contract and analytical services, including courses in 2d-electrophoresis and mass spectroscopy. Maintains related links for students, researchers and industry, with opportunities in New South Wales and Thebarton, South Australia.
- 492
- Guild BioSciences
- Offer protein isolation, purification, characterization, SDS PAGE, 2D electrophoresis, differential proteomic analysis, with proprietary prefractionation methods. Includes team overview and lists facilities at Charleston, South Carolina.
- 493
- Hybrigenics SA.
- Company aiming to discover new drug targets and therapeutic molecules by combining screening, mapping and validation of protein interaction pathways. Includes outline of facilities and analyses offered from Cambridge, Massachusetts.
- 494
- Shamrock Structures
- Offers integrated services with access to synchrotron beamtime for macromolecular crystallography data collection. Outlines cloning, purification, E. coli and Baculovirus expression systems, crystallization options and 3D structure determination at Woodridge, Illinois.
- 498
- 3rd qPCR Symposium & Workshop & Exhibition
- The congress, industrial exhibition and workshop will be held at the Center of Life Science in Freising Weihenstephan, Technical University Munich (Germany).